GUJARAT KIDNEY N SUP SP L
Latest filings
Next results: Wed, 4 Nov · Financial Results- Board to review September 2026 quarterly results on 4 November · Results
- Quarterly confirmation: all shares held in demat form · Compliance
- AGM Results: All 12 Resolutions Passed with 100% Approval · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
Operates hospitals providing kidney care and super-speciality medical services, and has expanded rapidly through acquisitions of multiple hospital and pathology businesses across India. Recently listed on BSE and NSE in December 2025, the company is now extending overseas with a board-approved plan to acquire 51 percent of Blue Tree Clinics LLC, a Dubai polyclinic offering plastic surgery, cosmetic, dental and chiropractic services. The Dubai target reported FY25 revenue of 10.54 million AED and net profit of 3.14 million AED. Subsidiaries brought in include Raj Pathology, Gujarat Surgical Hospital, Surya Hospital, Harmony Medicare, Parekh's Hospital and Patel Multispeciality Hospital, taking the group to a multi-hospital chain. Employee costs of 16.6 percent of revenue and other operating expenses of 39.4 percent are the largest cost lines.
Scorecard
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from GUJARAT KIDNEY N SUP SP L's filed financials and exchange disclosures
What does GUJARAT KIDNEY N SUP SP L do?
GUJARAT KIDNEY N SUP SP L is a Healthcare Services company listed on NSE and BSE, trading under the symbol GKSL.
Is GUJARAT KIDNEY N SUP SP L profitable?
Yes. Over the trailing twelve months GUJARAT KIDNEY N SUP SP L reported a net profit of ₹22 Cr on revenue of ₹116 Cr.
Does GUJARAT KIDNEY N SUP SP L pay a dividend?
Not in the latest reported year — GUJARAT KIDNEY N SUP SP L's dividend payout for FY26 was nil.
Is GUJARAT KIDNEY N SUP SP L debt-free?
No. It reported borrowings of ₹16 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹2.43 Cr after cash. Debt stands at 0.06× equity. That is lower than 78% of its 24 Hospital peers.
Is GUJARAT KIDNEY N SUP SP L expensive compared with its peers?
On trailing P/E, GUJARAT KIDNEY N SUP SP L ranks 19 of 30 in Hospital — cheaper than 38% of them, against an industry median of 42.2×. This is a position, not a valuation judgement.
How much does the GUJARAT KIDNEY N SUP SP L share price move in a day?
On a typical session GUJARAT KIDNEY N SUP SP L moves 1.18% — that is the median absolute close-to-close move across its last 202 trading days. MarketPing measures each filing's price reaction against it.
When are GUJARAT KIDNEY N SUP SP L's next results?
Financial Results on Wed, 4 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track GUJARAT KIDNEY N SUP SP L's announcements?
Every NSE and BSE filing by GUJARAT KIDNEY N SUP SP L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.